Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 65 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
641 15.6 months Advanced colorectal cancer 4 Chemotherapy
Hospital La Paz Spain 4/2004
Treatment Details: Patients: This Phase II study involved 91 patients with advanced colorectal cancer. Treatment: The treatment consisted of two chemotherapy drugs – irinotecan (camptosar, CPT-11) and ralti
 
642 15.6 months Metastatic renal cell carcinoma 5 Biologic therapy
Immunotherapy
Wake Forest University United States 6/2004
Treatment Details: Patients: This Phase II trial involved 30 patients with metastatic renal cell carcinoma; 19 men and 11 women. The median age was 62. Seventeen patients had undergone a prior nephrectomy.
 
643 15.6 months Malignant mesothelioma 4 Biologic therapy
Chemotherapy
University of Chicago Comprehensive Cancer Center United States 6/2012
Treatment Details: Patients: This phase II study involved malignant mesothelioma patients who were divided into two separate treatment groups. Group A consisted of 53 patients with a median age of 62 years;
 
644 15.6 months Advanced hepatocellular carcinoma 5 Biologic therapy
The University of Texas M. D. Anderson Cancer Center United States 2/2009
Treatment Details: Patients: This phase II study involved 40 advanced hepatocellular carcinoma patients with a median age of 64 years; 77.5% were male. Treatment: Patients were treated with a combination
 
645 15.6 months Metastatic breast cancer and advanced breast cancer 5 Biologic therapy
The Sarah Cannon Research Institute and Tennessee Oncology United States 12/2012
Treatment Details: Patients: This phase 2 study involved 83 women with metastatic or advanced breast cancer. The median patient age was 58 years. Treatment: Patients were treated with the biologic therap
 
646 15.5 months Malignant peritoneal mesothelioma 5 Chemotherapy
Radiation
Surgery
Azienda Ospedaliera-Università di Padova Italy 1/2013
Treatment Details: Patients: This phase 2 study involved 54 malignant pleural mesothelioma patients who had not received prior treatment. The median patient age was 63 years and 87% were male. Treatment:
 
647 15.5 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Centre René Gauducheau France 4/2014
Treatment Details: Patients: This phase 3 study involved metastatic colorectal cancer patients who were separated into four different groups based on treatment and their genetic status of the KRAS gene. Grou
 
648 15.5 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
Hormone
National Cancer Institute United States 9/2013
Treatment Details: Patients: This phase 2 study involved 23 metastatic castration-resistant prostate cancer patients who were previously treated with docetaxel-based chemotherapy. The median patient age was
 
649 15.5 months Metastatic hepatocellular (liver) or fibrolamellar carcinoma 4 Chemotherapy
Immunotherapy
The University of Texas M. D. Anderson Cancer Center United States 2/2003
Treatment Details: Patients: This Phase II trial involved 43 patients. Thirty-four had hepatocellular carcinoma and nine had fibrolamellar hepatocellular carcinoma. All had metastatic disease (TNM stages IV
 
650 15.5 months Platinum refractory or resistant ovarian cancer or resistant peritoneal cancer 5 Biologic therapy
Chemotherapy
Departments of Medical Oncology, Mayo United States 4/2011
Treatment Details: Patients: This study involved 18 women with platinum refractory or resistant ovarian or peritoneal cancer. The median patient age was 66 years. All patients had previously been treated wi
 
Page 65 of 187  | Previous Page  | Next Page